Brief: Cross Country Healthcare Q2 Adjusted EPS USD 0.69 Vs. IBES Estimate USD 0.61
02/08/2023 21:15
Aug 02 (Reuters) - Cross Country Healthcare Q2 adjusted EBITDA margin 8.2%. * Q2 revenue USD 540.695 million vs. IBES estimate USD 531.7 million * Q2 gross margin 22.8% * Q2 adjusted EBITDA USD 44.44 million * Q2 EPS USD 0.6 * Q2 net income USD 21.345 million
Recent news on Cross Country Healthcare
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Cross Country Healthcare Q1 revenue falls 18% but beats estimates
Brief: Cross Country Healthcare Q1 Adjusted EPS USD -0.03 Vs. IBES Estimate USD -0.04
Brief: Cross Country Healthcare To Be Acquired By Knox Lane In All-Cash Transaction Valued At $437 Million